Amundi STOXX Europe 600 Healthcare UCITS ETF Acc
HLT.PA
Euronext Paris- -
EUR
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Multi Units Luxembourg - Amundi STOXX Europe 600 Healthcare UCITS ETF Acc (HLT.PA) is a Luxembourg-domiciled SICAV structured as a UCITS-compliant exchange-traded fund that seeks to replicate, both upward and downward, the performance of the STOXX Europe 600 Health Care Net Return EUR Index through synthetic replication via total return swaps. The ETF provides investors with targeted exposure to the European healthcare sector, encompassing large-cap pharmaceutical, biotechnology, medical equipment and healthcare service companies across the STOXX Europe 600 universe; it employs a passive, long-only strategy with accumulating distribution policy, reinvesting dividends to enhance share price growth, and maintains a total expense ratio of 0.30%. Listed on Euronext Paris and other major exchanges including Frankfurt, Milan and London, the fund targets institutional and professional investors seeking sector-specific equity exposure without currency hedging, with assets under management exceeding EUR 895 million as of late 2025. Established with a first net asset value date of August 17, 2006 and headquartered at 9 Rue de Bitbourg, L-1273 Luxembourg, the ETF operates under the management of Amundi Asset Management SAS, with Société Générale Luxembourg serving as custodian. Products are distributed across Europe, including France, Germany, Italy, Luxembourg, Switzerland and the United Kingdom, reflecting broad geographic availability for European healthcare sector investments. Recent developments include multiple changes of characteristics notified in October 2025 and February 2025, alongside a prospectus amendment for name harmonization affecting various Multi Units Luxembourg sub-funds under the Amundi brand. In September 2025, Multi Units Luxembourg announced mergers by absorption for several related ETFs to achieve economies of scale and larger fund sizes, though this specific healthcare product was not directly involved. Amundi, the fund provider, pursued strategic expansions such as a November 2025 long-term equity partnership with Intermediate Capital Group (ICG) for private markets distribution and a November 2025 collaboration with Euronext to launch a new ETF focused on European strategic autonomy financing.